+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Smart Pills Technology Market By Application, By Target Area, By Disease Indication, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • PDF Icon

    Report

  • 234 Pages
  • March 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640470
UP TO OFF until Oct 24th 2024
Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery. They are majorly available in the form of vitamin capsule-sized pills and possess a small wearable sensor patch, an application on a mobile device, and a provider portal. Once swallowed, it gets activated in the gut; the sensors provide information about the patient’s health parameters and the effectiveness of medication treatment leading to more informed healthcare decisions and optimized therapies. Moreover, smart pills have revolutionized the field of gastrointestinal diagnosis. These pills are non-invasive, and hence the user can be a potent alternative approach against invasive procedures such as gastrointestinal endoscopy/colonoscopy.

A considerable increase in the geriatric population, rise in chronic disorders such as cancer, diabetes, and others, and surge in prevalence of lifestyle-related disorders, such as obesity, gastroesophageal reflux disease (GERD), gastric ulcers, and others majorly drive the growth of the smart pills market. In addition, increased R&Dinvestments in developing smart pills further boost the market growth. However, stringent government regulations regarding the increased use of these devices and the high cost associated with the ingestible sensors are the factors anticipated to restrain the growth of the market.

The smart pills market is segmented based on application, target area, disease indication, end-users, and region. On the basis of application, the market is divided into capsule endoscopy, drug delivery, and patient monitoring. By target areas, the market is divided into the esophagus, stomach, small intestine, and large intestine. By disease indication, the market is segmented into Barrett's esophagus disease, small bowel disease (bifurcated into Crohn's disease, small bowel tumor, celiac disease, and others), Colon Disease, and Others. By end-user, the smart pills market is divided into hospitals & clinics, diagnostic centers, and research centers.

By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Product development and research collaborations are the key strategies adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global smart pills market.

The key players operating in the global smart pills market include CapsoVision, Inc., Check-Cap Ltd., HQ.Inc., IntroMedic Co., Ltd, JINSHAN Science & Technology, Koninklijke Philips N.V., Medtronic plc, OLYMPUS Corporation, Proteus Digital Health, RF Co., Ltd.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the smart pills technology market analysis from 2020 to 2030 to identify the prevailing smart pills technology market opportunities.
  • The Market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the smart pills technology market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global smart pills technology market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


BY APPLICATION

  • Capsule Endoscopy
  • Drug Delivery
  • Patient Monitoring

BY TARGET AREA

  • Esophagus
  • Stomach
  • Small Intestine
  • Large Intestine

BY DISEASE INDICATION

  • Barrett'S Esophagus
  • Small Bowel Diseases
  • Colon Cancer
  • Others

BY END USER

  • Hospitals and Clinics
  • Diagnostic Centres
  • Research Centres

BY REGION

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest Of Asia Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • RF Co., Ltd
  • JINSHAN Science and Technology
  • Proteus Digital Health
  • HQ, Inc.
  • CapsoVision, Inc.
  • Medtronic Plc.
  • Olympus Corporations
  • IntroMedic Co., Ltd
  • Check Cap
  • Koninklijke Philips N.V

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: SMART PILLS TECHNOLOGY MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Capsule Endoscopy
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Drug Delivery
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Patient Monitoring
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA
5.1 Overview
5.1.1 Market size and forecast
5.2 Esophagus
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Stomach
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Small Intestine
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Large Intestine
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Barrett'S Esophagus
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Small Bowel Diseases
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Colon Cancer
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Others
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: SMART PILLS TECHNOLOGY MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Hospitals and Clinics
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Diagnostic Centres
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Research Centres
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: SMART PILLS TECHNOLOGY MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Application
8.2.3 North America Market size and forecast, by Target Area
8.2.4 North America Market size and forecast, by Disease Indication
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Application
8.2.6.1.2 Market size and forecast, by Target Area
8.2.6.1.3 Market size and forecast, by Disease Indication
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Application
8.2.6.2.2 Market size and forecast, by Target Area
8.2.6.2.3 Market size and forecast, by Disease Indication
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Application
8.2.6.3.2 Market size and forecast, by Target Area
8.2.6.3.3 Market size and forecast, by Disease Indication
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Application
8.3.3 Europe Market size and forecast, by Target Area
8.3.4 Europe Market size and forecast, by Disease Indication
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Application
8.3.6.1.2 Market size and forecast, by Target Area
8.3.6.1.3 Market size and forecast, by Disease Indication
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Application
8.3.6.2.2 Market size and forecast, by Target Area
8.3.6.2.3 Market size and forecast, by Disease Indication
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 U.K.
8.3.6.3.1 Market size and forecast, by Application
8.3.6.3.2 Market size and forecast, by Target Area
8.3.6.3.3 Market size and forecast, by Disease Indication
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Application
8.3.6.4.2 Market size and forecast, by Target Area
8.3.6.4.3 Market size and forecast, by Disease Indication
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Application
8.3.6.5.2 Market size and forecast, by Target Area
8.3.6.5.3 Market size and forecast, by Disease Indication
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Application
8.3.6.6.2 Market size and forecast, by Target Area
8.3.6.6.3 Market size and forecast, by Disease Indication
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Application
8.4.3 Asia-Pacific Market size and forecast, by Target Area
8.4.4 Asia-Pacific Market size and forecast, by Disease Indication
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Application
8.4.6.1.2 Market size and forecast, by Target Area
8.4.6.1.3 Market size and forecast, by Disease Indication
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Application
8.4.6.2.2 Market size and forecast, by Target Area
8.4.6.2.3 Market size and forecast, by Disease Indication
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Market size and forecast, by Application
8.4.6.3.2 Market size and forecast, by Target Area
8.4.6.3.3 Market size and forecast, by Disease Indication
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Market size and forecast, by Application
8.4.6.4.2 Market size and forecast, by Target Area
8.4.6.4.3 Market size and forecast, by Disease Indication
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Application
8.4.6.5.2 Market size and forecast, by Target Area
8.4.6.5.3 Market size and forecast, by Disease Indication
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest Of Asia Pacific
8.4.6.6.1 Market size and forecast, by Application
8.4.6.6.2 Market size and forecast, by Target Area
8.4.6.6.3 Market size and forecast, by Disease Indication
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Application
8.5.3 LAMEA Market size and forecast, by Target Area
8.5.4 LAMEA Market size and forecast, by Disease Indication
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Application
8.5.6.1.2 Market size and forecast, by Target Area
8.5.6.1.3 Market size and forecast, by Disease Indication
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 South Africa,
8.5.6.2.1 Market size and forecast, by Application
8.5.6.2.2 Market size and forecast, by Target Area
8.5.6.2.3 Market size and forecast, by Disease Indication
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 Saudi Arabia
8.5.6.3.1 Market size and forecast, by Application
8.5.6.3.2 Market size and forecast, by Target Area
8.5.6.3.3 Market size and forecast, by Disease Indication
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Application
8.5.6.4.2 Market size and forecast, by Target Area
8.5.6.4.3 Market size and forecast, by Disease Indication
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 RF Co., Ltd
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 JINSHAN Science and Technology
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Proteus Digital Health
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 HQ, Inc.
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 CapsoVision, Inc.
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Medtronic Plc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Olympus Corporations
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 IntroMedic Co., Ltd
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Check Cap
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Koninklijke Philips N.V
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Smart Pills Technology Market, by Application, 2020-2030, ($Million)
Table 2. Smart Pills Technology Market Revenue, for Capsule Endoscopy, by Region, 2020-2030, ($Million)
Table 3. Smart Pills Technology Market Capsule Endoscopy by Country, 2020-2030, ($Million)
Table 4. Smart Pills Technology Market Revenue, for Drug Delivery, by Region, 2020-2030, ($Million)
Table 5. Smart Pills Technology Market Drug Delivery by Country, 2020-2030, ($Million)
Table 6. Smart Pills Technology Market Revenue, for Patient Monitoring, by Region, 2020-2030, ($Million)
Table 7. Smart Pills Technology Market Patient Monitoring by Country, 2020-2030, ($Million)
Table 8. Global Smart Pills Technology Market, by Target Area, 2020-2030, ($Million)
Table 9. Smart Pills Technology Market Revenue, for Esophagus, by Region, 2020-2030, ($Million)
Table 10. Smart Pills Technology Market Esophagus by Country, 2020-2030, ($Million)
Table 11. Smart Pills Technology Market Revenue, for Stomach, by Region, 2020-2030, ($Million)
Table 12. Smart Pills Technology Market Stomach by Country, 2020-2030, ($Million)
Table 13. Smart Pills Technology Market Revenue, for Small Intestine, by Region, 2020-2030, ($Million)
Table 14. Smart Pills Technology Market Small Intestine by Country, 2020-2030, ($Million)
Table 15. Smart Pills Technology Market Revenue, for Large Intestine, by Region, 2020-2030, ($Million)
Table 16. Smart Pills Technology Market Large Intestine by Country, 2020-2030, ($Million)
Table 17. Global Smart Pills Technology Market, by Disease Indication, 2020-2030, ($Million)
Table 18. Smart Pills Technology Market Revenue, for Barrett's Esophagus, by Region, 2020-2030, ($Million)
Table 19. Smart Pills Technology Market Barrett's Esophagus by Country, 2020-2030, ($Million)
Table 20. Smart Pills Technology Market Revenue, for Small Bowel Diseases, by Region, 2020-2030, ($Million)
Table 21. Smart Pills Technology Market Small Bowel Diseases by Country, 2020-2030, ($Million)
Table 22. Smart Pills Technology Market Revenue, for Colon Cancer, by Region, 2020-2030, ($Million)
Table 23. Smart Pills Technology Market Colon Cancer by Country, 2020-2030, ($Million)
Table 24. Smart Pills Technology Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 25. Smart Pills Technology Market Others by Country, 2020-2030, ($Million)
Table 26. Global Smart Pills Technology Market, by End-user, 2020-2030, ($Million)
Table 27. Smart Pills Technology Market Revenue, for Hospitals and Clinics, by Region, 2020-2030, ($Million)
Table 28. Smart Pills Technology Market Hospitals and Clinics by Country, 2020-2030, ($Million)
Table 29. Smart Pills Technology Market Revenue, for Diagnostic Centres, by Region, 2020-2030, ($Million)
Table 30. Smart Pills Technology Market Diagnostic Centres by Country, 2020-2030, ($Million)
Table 31. Smart Pills Technology Market Revenue, for Research Centres, by Region, 2020-2030, ($Million)
Table 32. Smart Pills Technology Market Research Centres by Country, 2020-2030, ($Million)
Table 33. Smart Pills Technology Market, by Region, 2020-2030, ($Million)
Table 34. North America Smart Pills Technology Market, by Application, 2020-2030, ($Million)
Table 35. North America Smart Pills Technology Market, by Target Area, 2020-2030, ($Million)
Table 36. North America Smart Pills Technology Market, by Disease Indication, 2020-2030, ($Million)
Table 37. North America Smart Pills Technology Market, by End-user, 2020-2030, ($Million)
Table 38. North America Smart Pills Technology Market, by Country, 2020-2030, ($Million)
Table 39. U.S. Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 40. U.S. Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 41. U.S. Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 42. U.S. Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 43. Canada Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 44. Canada Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 45. Canada Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 46. Canada Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 47. Mexico Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 48. Mexico Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 49. Mexico Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 50. Mexico Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 51. Europe Smart Pills Technology Market, by Application, 2020-2030, ($Million)
Table 52. Europe Smart Pills Technology Market, by Target Area, 2020-2030, ($Million)
Table 53. Europe Smart Pills Technology Market, by Disease Indication, 2020-2030, ($Million)
Table 54. Europe Smart Pills Technology Market, by End-user, 2020-2030, ($Million)
Table 55. Europe Smart Pills Technology Market, by Country, 2020-2030, ($Million)
Table 56. Germany Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 57. Germany Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 58. Germany Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 59. Germany Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 60. France Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 61. France Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 62. France Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 63. France Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 64. U.K. Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 65. U.K. Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 66. U.K. Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 67. U.K. Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 68. Italy Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 69. Italy Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 70. Italy Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 71. Italy Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 72. Spain Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 73. Spain Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 74. Spain Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 75. Spain Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 76. Rest of Europe Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 77. Rest of Europe Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 78. Rest of Europe Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 79. Rest of Europe Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 80. Asia-Pacific Smart Pills Technology Market, by Application, 2020-2030, ($Million)
Table 81. Asia-Pacific Smart Pills Technology Market, by Target Area, 2020-2030, ($Million)
Table 82. Asia-Pacific Smart Pills Technology Market, by Disease Indication, 2020-2030, ($Million)
Table 83. Asia-Pacific Smart Pills Technology Market, by End-user, 2020-2030, ($Million)
Table 84. Asia-Pacific Smart Pills Technology Market, by Country, 2020-2030, ($Million)
Table 85. Japan Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 86. Japan Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 87. Japan Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 88. Japan Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 89. China Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 90. China Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 91. China Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 92. China Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 93. Australia Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 94. Australia Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 95. Australia Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 96. Australia Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 97. India Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 98. India Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 99. India Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 100. India Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 101. South Korea Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 102. South Korea Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 103. South Korea Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 104. South Korea Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 105. Rest of Asia-Pacific Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 106. Rest of Asia-Pacific Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 107. Rest of Asia-Pacific Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 108. Rest of Asia-Pacific Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 109. LAMEA Smart Pills Technology Market, by Application, 2020-2030, ($Million)
Table 110. LAMEA Smart Pills Technology Market, by Target Area, 2020-2030, ($Million)
Table 111. LAMEA Smart Pills Technology Market, by Disease Indication, 2020-2030, ($Million)
Table 112. LAMEA Smart Pills Technology Market, by End-user, 2020-2030, ($Million)
Table 113. LAMEA Smart Pills Technology Market, by Country, 2020-2030, ($Million)
Table 114. Brazil Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 115. Brazil Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 116. Brazil Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 117. Brazil Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 118. South Africa, Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 119. South Africa, Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 120. South Africa, Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 121. South Africa, Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 122. Saudi Arabia Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 123. Saudi Arabia Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 124. Saudi Arabia Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 125. Saudi Arabia Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 126. Rest of LAMEA Smart Pills Technology Market by Application 2020-2030, ($Million)
Table 127. Rest of LAMEA Smart Pills Technology Market by Target Area 2020-2030, ($Million)
Table 128. Rest of LAMEA Smart Pills Technology Market by Disease Indication 2020-2030, ($Million)
Table 129. Rest of LAMEA Smart Pills Technology Market by End-user 2020-2030, ($Million)
Table 130. Rf Co., Ltd: Company Snapshot
Table 131. Rf Co., Ltd: Operating Segments
Table 132. Rf Co., Ltd: Product Portfolio
Table 133. Rf Co., Ltd: Net Sales
Table 134. Rf Co., Ltd: Key Stratergies
Table 135. Jinshan Science and Technology: Company Snapshot
Table 136. Jinshan Science and Technology: Operating Segments
Table 137. Jinshan Science and Technology: Product Portfolio
Table 138. Jinshan Science and Technology: Net Sales
Table 139. Jinshan Science and Technology: Key Stratergies
Table 140. Proteus Digital Health: Company Snapshot
Table 141. Proteus Digital Health: Operating Segments
Table 142. Proteus Digital Health: Product Portfolio
Table 143. Proteus Digital Health: Net Sales
Table 144. Proteus Digital Health: Key Stratergies
Table 145. Hq, Inc.: Company Snapshot
Table 146. Hq, Inc.: Operating Segments
Table 147. Hq, Inc.: Product Portfolio
Table 148. Hq, Inc.: Net Sales
Table 149. Hq, Inc.: Key Stratergies
Table 150. Capsovision, Inc.: Company Snapshot
Table 151. Capsovision, Inc.: Operating Segments
Table 152. Capsovision, Inc.: Product Portfolio
Table 153. Capsovision, Inc.: Net Sales
Table 154. Capsovision, Inc.: Key Stratergies
Table 155. Medtronic plc.: Company Snapshot
Table 156. Medtronic plc.: Operating Segments
Table 157. Medtronic plc.: Product Portfolio
Table 158. Medtronic plc.: Net Sales
Table 159. Medtronic plc.: Key Stratergies
Table 160. Olympus Corporations: Company Snapshot
Table 161. Olympus Corporations: Operating Segments
Table 162. Olympus Corporations: Product Portfolio
Table 163. Olympus Corporations: Net Sales
Table 164. Olympus Corporations: Key Stratergies
Table 165. Intromedic Co., Ltd: Company Snapshot
Table 166. Intromedic Co., Ltd: Operating Segments
Table 167. Intromedic Co., Ltd: Product Portfolio
Table 168. Intromedic Co., Ltd: Net Sales
Table 169. Intromedic Co., Ltd: Key Stratergies
Table 170. Check Cap: Company Snapshot
Table 171. Check Cap: Operating Segments
Table 172. Check Cap: Product Portfolio
Table 173. Check Cap: Net Sales
Table 174. Check Cap: Key Stratergies
Table 175. Koninklijke Philips N.V: Company Snapshot
Table 176. Koninklijke Philips N.V: Operating Segments
Table 177. Koninklijke Philips N.V: Product Portfolio
Table 178. Koninklijke Philips N.V: Net Sales
Table 179. Koninklijke Philips N.V: Key Stratergies
LIST OF FIGURES
Figure 1. Smart Pills Technology Market Segmentation
Figure 2. Smart Pills Technology Market, 2020-2030
Figure 3. Smart Pills Technology Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Smart Pills Technology Market:Drivers, Restraints and Opportunities
Figure 11. Smart Pills Technology Market, by Application, 2020 (%)
Figure 12. Comparative Share Analysis of Capsule Endoscopy Smart Pills Technology Market, 2020-2030 (%)
Figure 13. Comparative Share Analysis of Drug Delivery Smart Pills Technology Market, 2020-2030 (%)
Figure 14. Comparative Share Analysis of Patient Monitoring Smart Pills Technology Market, 2020-2030 (%)
Figure 15. Smart Pills Technology Market, by Target Area, 2020 (%)
Figure 16. Comparative Share Analysis of Esophagus Smart Pills Technology Market, 2020-2030 (%)
Figure 17. Comparative Share Analysis of Stomach Smart Pills Technology Market, 2020-2030 (%)
Figure 18. Comparative Share Analysis of Small Intestine Smart Pills Technology Market, 2020-2030 (%)
Figure 19. Comparative Share Analysis of Large Intestine Smart Pills Technology Market, 2020-2030 (%)
Figure 20. Smart Pills Technology Market, by Disease Indication, 2020 (%)
Figure 21. Comparative Share Analysis of Barrett's Esophagus Smart Pills Technology Market, 2020-2030 (%)
Figure 22. Comparative Share Analysis of Small Bowel Diseases Smart Pills Technology Market, 2020-2030 (%)
Figure 23. Comparative Share Analysis of Colon Cancer Smart Pills Technology Market, 2020-2030 (%)
Figure 24. Comparative Share Analysis of Others Smart Pills Technology Market, 2020-2030 (%)
Figure 25. Smart Pills Technology Market, by End-user, 2020 (%)
Figure 26. Comparative Share Analysis of Hospitals and Clinics Smart Pills Technology Market, 2020-2030 (%)
Figure 27. Comparative Share Analysis of Diagnostic Centres Smart Pills Technology Market, 2020-2030 (%)
Figure 28. Comparative Share Analysis of Research Centres Smart Pills Technology Market, 2020-2030 (%)
Figure 29. Smart Pills Technology Market by Region, 2020
Figure 30. U.S. Smart Pills Technology Market, 2020-2030 ($Million)
Figure 31. Canada Smart Pills Technology Market, 2020-2030 ($Million)
Figure 32. Mexico Smart Pills Technology Market, 2020-2030 ($Million)
Figure 33. Germany Smart Pills Technology Market, 2020-2030 ($Million)
Figure 34. France Smart Pills Technology Market, 2020-2030 ($Million)
Figure 35. U.K. Smart Pills Technology Market, 2020-2030 ($Million)
Figure 36. Italy Smart Pills Technology Market, 2020-2030 ($Million)
Figure 37. Spain Smart Pills Technology Market, 2020-2030 ($Million)
Figure 38. Rest of Europe Smart Pills Technology Market, 2020-2030 ($Million)
Figure 39. Japan Smart Pills Technology Market, 2020-2030 ($Million)
Figure 40. China Smart Pills Technology Market, 2020-2030 ($Million)
Figure 41. Australia Smart Pills Technology Market, 2020-2030 ($Million)
Figure 42. India Smart Pills Technology Market, 2020-2030 ($Million)
Figure 43. South Korea Smart Pills Technology Market, 2020-2030 ($Million)
Figure 44. Rest of Asia-Pacific Smart Pills Technology Market, 2020-2030 ($Million)
Figure 45. Brazil Smart Pills Technology Market, 2020-2030 ($Million)
Figure 46. South Africa, Smart Pills Technology Market, 2020-2030 ($Million)
Figure 47. Saudi Arabia Smart Pills Technology Market, 2020-2030 ($Million)
Figure 48. Rest of LAMEA Smart Pills Technology Market, 2020-2030 ($Million)
Figure 49. Top Winning Strategies, by Year
Figure 50. Top Winning Strategies, by Development
Figure 51. Top Winning Strategies, by Company
Figure 52. Product Mapping of Top 10 Players
Figure 53. Competitive Dashboard
Figure 54. Competitive Heatmap of Top 10 Key Players
Figure 55. Rf Co. Ltd.: Net Sales, ($Million)
Figure 56. Jinshan Science and Technology.: Net Sales, ($Million)
Figure 57. Proteus Digital Health.: Net Sales, ($Million)
Figure 58. Hq, Inc. Net Sales, ($Million)
Figure 59. Capsovision, Inc. Net Sales, ($Million)
Figure 60. Medtronic PLC. Net Sales, ($Million)
Figure 61. Olympus Corporations.: Net Sales, ($Million)
Figure 62. Intromedic Co. Ltd.: Net Sales, ($Million)
Figure 63. Check Cap.: Net Sales, ($Million)
Figure 64. Koninklijke Philips N.V.: Net Sales, ($Million)

Executive Summary

The Smart Pill Technology Market size was valued at $3.2 billion in 2020 and is estimated to reach $7.5 billion by 2030, growing at a CAGR of 8.8% from 2021 to 2030.

The smart pill is a technological innovation that has bridged the unsought gap between healthcare and digital technology. The technology is implanted in tiny electronic appliances (such as sensors, cameras, trackers, and others), that are embedded into a small pill-sized device for monitoring and diagnosis of several diseases. The advent of novel smart pill technologies has revolutionized gastrointestinal (GI) monitoring and diagnosis techniques. Novel features such as non-invasiveness, patient convenience, and real-time monitoring offered by smart pills popularly boost their adoption in the treatment of numerous diseases. The global Smart Pill Technology Market trends are the growth in adoption of capsule endoscopy, increase in demand for smart pills in GI monitoring, and the rise in prevalence of gastrointestinal diseases. However, factors such as high costs, limited technical know-how, and low acceptance among patients (fear of ingesting electronic devices) are expected to restrain the growth of the market.

The capsule endoscopy application generated the highest revenue and is expected to maintain this dominance throughout the forecast period. This is attributed to the increased prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), irritable small bowel syndrome, ulcers, and others. However, the patient monitoring segment is expected to register the highest growth rate during the forecast period, owing to a rise in awareness regarding problems related to medication nonadherence.

On the basis of the target area, the Smart Pill Industry is classified into the esophagus, stomach, small intestine, and large intestine. The esophagus target area dominates the global smart pill market. This is attributed to the significant increase in esophagus disorders such as Crohn’s disease, celiac disease, and others.

By region, the smart pills market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest Smart Pill Technology Market share in 2020 and is expected to retain its dominance throughout the forecast period owing to factors such as technological advancements in the healthcare sector, an increase in the incidence of colorectal cancer, and regulatory approval of new products. As per the American Cancer Society, 95,520 new cases of colon cancer and 39,910 new cases of rectal cancer were diagnosed in the U.S. by the end of 2019. This is provided growth opportunities for players operating in this region. Asia-Pacific witnessed the highest growth rate for the smart pills market and is expected to remain dominant throughout the forecast period attributed to the rise in expenditure on healthcare and improvement in the medical & healthcare infrastructure are the key factors driving the Smart Pill Technology Market growth in upcoming years.

The key players that operate in the smart pills market have adopted product approval as their key developmental strategy and focus on launching innovative products to cater to consumer requirements and to strengthen their market share. The major companies profiled in the report are Proteus Digital Health, HQ, Inc., CapsoVision, Inc., Medtronic Plc., Olympus Corporations, IntroMedic Co., Ltd, RF Co., Ltd, JINSHAN Science & Technology, Check-Cap, and Koninklijke Philips N.V.

Key findings of the Study

  • By application, the capsule endoscopy segment was the highest contributor to the market in 2020.
  • On the basis of target areas, the esophagus segment dominated the market in 2020 and is expected to continue this trend during the forecast period.
  • On the basis of disease indication, Barrett’s esophagus disease segment dominated the market in 2020 and is expected to continue this trend during the forecast period.
  • On the basis of end-users, the hospital segment dominated the market in 2020 and is expected to continue this trend during the forecast period.
  • Region-wise, North America garnered the largest revenue share in 2020, however, Asia Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • RF Co., Ltd
  • JINSHAN Science and Technology
  • Proteus Digital Health
  • HQ, Inc.
  • CapsoVision, Inc.
  • Medtronic Plc.
  • Olympus Corporations
  • IntroMedic Co., Ltd
  • Check Cap
  • Koninklijke Philips N.V

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...